FibroGen, Inc. Shares Shoot Up On Positive Results From Phase 2 Study Of Pamrevlumab
August 08, 2017 at 11:46 AM EDT
FGEN opened trading yesterday at $34.90 which was down from the previous day’s trading close of $35.00. FGEN closed trading yesterday at $33.40 and spiked up after hours to $53.95, equivalent to a 62% increase from the closing price.
